Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Asthenia
ADR ID BADD_A00362
ADR Hierarchy
08      General disorders and administration site conditions
08.01      General system disorders NEC
08.01.01      Asthenic conditions
08.01.01.001      Asthenia
Description Clinical sign or symptom manifested as debility, or lack or loss of strength and energy. [MeSH]
MedDRA Code 10003549
MeSH ID D001247; D009440; D000073496
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Adynamia | Asthenia | Collapse of legs | Debility | Debility marked | Debility, unspecified | Feeling of total lack of energy | Feelings of weakness | General debility | Loss of energy | Nervous debility | Neurasthaenia | Neurasthenia | Strength loss of | Weakness | Weakness generalised | Weakness generalized | Weakness postural | Energy decreased | Frailty | Weakness worsened | Hyposthenia | Cerebro-asthenic syndrome
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01981Salmeterol--
BADD_D01989Saquinavir mesylate--
BADD_D01990Sargramostim--
BADD_D01992Saxagliptin0.000982%
BADD_D01994Scopolamine0.001414%
BADD_D01996Sebelipase alfa--
BADD_D01999Secretin--
BADD_D02002Selegiline--
BADD_D02003Selegiline hydrochloride--
BADD_D02006Selexipag0.003619%
BADD_D02007Semaxanib--
BADD_D02010Sertraline--
BADD_D02011Sertraline hydrochloride--
BADD_D02012Sevelamer--
BADD_D02014Sevelamer hydrochloride--
BADD_D02015Sevoflurane--
BADD_D02016Sibutramine--
BADD_D02017Sibutramine hydrochloride--
BADD_D02018Sildenafil--
BADD_D02020Silodosin--
BADD_D02025Simeprevir--
BADD_D02026Simvastatin0.000543%
BADD_D02028Sirolimus--
BADD_D02029Sitagliptin0.002706%
BADD_D02031Sitaxentan--
BADD_D02032Sodium acetate--
BADD_D02033Sodium aurothiomalate--
BADD_D02037Sodium cation--
BADD_D02038Sodium ferric gluconate complex-
BADD_D02039Sodium fluoride--
The 37th Page    First    Pre   37 38 39 40 41    Next   Last    Total 47 Pages
ADReCS-Target
ADR Term Drug Name Target